• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Condello Regarding Article, "Cytokine Hemadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial".

作者信息

Condello Ignazio

机构信息

Department of Cardiac Surgery, Anthea Hospital, GVM Care & Research, Bari, Italy.

出版信息

Circulation. 2022 Sep 6;146(10):e138-e139. doi: 10.1161/CIRCULATIONAHA.122.060844.

DOI:10.1161/CIRCULATIONAHA.122.060844
PMID:36067278
Abstract
摘要

相似文献

1
Letter by Condello Regarding Article, "Cytokine Hemadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial".康代洛就《心脏手术期间细胞因子血液吸附与感染性心内膜炎标准手术治疗（REMOVE）：一项多中心随机对照试验的结果》一文所写的信。
Circulation. 2022 Sep 6;146(10):e138-e139. doi: 10.1161/CIRCULATIONAHA.122.060844.
2
Response by Diab et al to Letter Regarding Article, "Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial".迪亚布等人对关于文章《心脏手术期间细胞因子血液吸附与感染性心内膜炎的标准手术治疗（REMOVE）：一项多中心随机对照试验的结果》的信件的回复
Circulation. 2022 Sep 6;146(10):e140. doi: 10.1161/CIRCULATIONAHA.122.061219.
3
Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial.心脏手术中细胞因子血液吸附与感染性心内膜炎标准手术治疗的比较（REMOVE）：多中心随机对照试验的结果。
Circulation. 2022 Mar 29;145(13):959-968. doi: 10.1161/CIRCULATIONAHA.121.056940. Epub 2022 Feb 25.
4
Assessing efficacy of CytoSorb haemoadsorber for prevention of organ dysfunction in cardiac surgery patients with infective endocarditis: REMOVE-protocol for randomised controlled trial.评估 CytoSorb 血液吸附器预防感染性心内膜炎心脏手术患者器官功能障碍的疗效：随机对照试验的 REMOVE 方案。
BMJ Open. 2020 Mar 30;10(3):e031912. doi: 10.1136/bmjopen-2019-031912.
5
The effect of perioperative hemadsorption in patients operated for acute infective endocarditis-A randomized controlled study.围手术期血液吸附治疗急性感染性心内膜炎患者的效果：一项随机对照研究。
Artif Organs. 2021 Nov;45(11):1328-1337. doi: 10.1111/aor.14019. Epub 2021 Jul 5.
6
CytoResc - "CytoSorb" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial.CytoResc - "CytoSorb" 救治方案用于治疗 COVID-19 细胞因子风暴危重症患者：一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Jun 26;21(1):577. doi: 10.1186/s13063-020-04501-0.
7
Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series.体外循环心脏手术期间急性感染性心内膜炎患者的血液吸附治疗——病例系列
Int J Artif Organs. 2017 May 29;40(5):240-249. doi: 10.5301/ijao.5000583. Epub 2017 May 19.
8
Machine learning to support decision-making for cardiac surgery during the acute phase of infective endocarditis.机器学习辅助感染性心内膜炎急性期心脏手术的决策制定
Heart. 2017 Sep;103(18):1396-1397. doi: 10.1136/heartjnl-2017-311512. Epub 2017 May 8.
9
Rationale, design, and methods for the early surgery in infective endocarditis study (ENDOVAL 1): a multicenter, prospective, randomized trial comparing the state-of-the-art therapeutic strategy versus early surgery strategy in infective endocarditis.感染性心内膜炎早期手术研究（ENDOVAL 1）的原理、设计与方法：一项多中心、前瞻性、随机试验，比较感染性心内膜炎的现行最佳治疗策略与早期手术策略。
Am Heart J. 2008 Sep;156(3):431-6. doi: 10.1016/j.ahj.2008.04.006. Epub 2008 Jul 2.
10
Anesthesia Considerations in Infective Endocarditis.感染性心内膜炎的麻醉考虑因素。
Anesthesiology. 2022 Apr 1;136(4):633-656. doi: 10.1097/ALN.0000000000004130.